Skip to content
  1. Home
  2. Latest news
  3. Health & wellness
  4. Diabesity: The pandemic impacting populations around the globe
Diabesity: Global Epidemic Lede

Diabesity: The pandemic impacting populations around the globe

Obesity and diabetes rates are increasing so much that there’s a term for it: diabesity. Here’s what you should know about this worldwide health crisis.

They’re sobering statistics. Between 1980 and 2013, the number of overweight and obese people grew from 857 million to 2.1 billion globally. Today, over a quarter of those who are obese also have type 2 diabetes.
On their own, obesity and diabetes can lead to serious health complications—but when combined, “diabesity,” as experts are calling the simultaneous rise in both conditions, can really leave a detrimental mark on the health of people in nearly every corner of the globe.

As we mark World Diabetes Day on November 14, see how Johnson & Johnson is lending its support to help with the health crisis—and what steps you can take to be your best, healthy self.

Diabesity: A Global Pandemic Infographic-compressed.jpg

Here’s how you can learn more about the growing impact of diabetes and obesity around the world.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.